Terms: = Leukemia AND RSPO2, Q6UXX9, 340419, ENSG00000147655, MGC43342, MGC35555
4 results:
1. Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RW
Lee H; Sun R; Niehrs C
J Biol Chem; 2022 Feb; 298(2):101586. PubMed ID: 35032551
[TBL] [Abstract] [Full Text] [Related]
2. rspo2 inhibits BMP signaling to promote self-renewal in acute myeloid leukemia.
Sun R; He L; Lee H; Glinka A; Andresen C; Hübschmann D; Jeremias I; Müller-Decker K; Pabst C; Niehrs C
Cell Rep; 2021 Aug; 36(7):109559. PubMed ID: 34407399
[TBL] [Abstract] [Full Text] [Related]
3. Targeting RSPO3-LGR4 Signaling for leukemia Stem Cell Eradication in Acute Myeloid leukemia.
Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY
Cancer Cell; 2020 Aug; 38(2):263-278.e6. PubMed ID: 32559496
[TBL] [Abstract] [Full Text] [Related]
4. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
Katoh M; Katoh M
Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
[TBL] [Abstract] [Full Text] [Related]
